用尤瑞克林与丁苯肽治疗大面积脑梗死的效果探析
发布时间：2018-12-10 08:56
【摘要】：目的 :探讨用尤瑞克林与丁苯肽治疗大面积脑梗死的临床效果。方法 :将我院收治的100例大面积脑梗死患者作为本次研究的对象。按照治疗方法的不同,将这100例患者分为常规组(49例)和研究组(51例)。对常规组患者进行常规治疗,对研究组患者在进行常规治疗的基础上加用尤瑞克林与丁苯肽进行治疗,然后比较两组患者治疗的总有效率、病死率、NIHSS评分、ADL评分及其不良反应的发生率。结果 :(1)经治疗,研究组患者治疗的总有效率明显高于常规组患者,其病死率明显低于常规组患者,差异有统计学意义(P0.05)。(2)经治疗,研究组患者的NIHSS评分明显低于常规组患者,其ADL评分明显高于常规组患者,差异有统计学意义(P0.05)。(3)两组患者不良反应的发生率相比差异无统计学意义(P0.05)。结论 :临床上在对大面积脑梗死患者进行常规治疗的同时,加用尤瑞克林与丁苯肽对其进行治疗的效果显著,能有效地提高其治疗的效果,降低其死亡率,且用药较为安全。
[Abstract]:Objective: to investigate the clinical effect of eurexine and butadiene peptide in the treatment of large area cerebral infarction. Methods: 100 patients with large-area cerebral infarction in our hospital were selected as the object of this study. According to the different treatment methods, the 100 patients were divided into routine group (49 cases) and study group (51 cases). The patients in the routine group were treated with routine therapy, and the patients in the study group were treated with eurexine and butadiene peptide on the basis of routine treatment. The total effective rate, mortality and NIHSS score were compared between the two groups. ADL score and the incidence of adverse reactions. Results: (1) after treatment, the total effective rate of the study group was significantly higher than that of the routine group, and the mortality was significantly lower than that of the routine group (P0.05). (2). The NIHSS score of the study group was significantly lower than that of the routine group, and the ADL score of the study group was significantly higher than that of the routine group. The difference was statistically significant (P0.05). (3). There was no significant difference in the incidence of adverse reactions between the two groups (P0.05). Conclusion: in addition to routine treatment of patients with large area cerebral infarction, the effect of Urikline and butadieneptide is remarkable, which can effectively improve the effect of treatment and reduce the mortality of patients with cerebral infarction, and it is safe to use drugs.
【作者单位】： 福建医科大学附属泉州市第一医院神经内科;
【分类号】：R743.33
[Abstract]:Objective: to investigate the clinical effect of eurexine and butadiene peptide in the treatment of large area cerebral infarction. Methods: 100 patients with large-area cerebral infarction in our hospital were selected as the object of this study. According to the different treatment methods, the 100 patients were divided into routine group (49 cases) and study group (51 cases). The patients in the routine group were treated with routine therapy, and the patients in the study group were treated with eurexine and butadiene peptide on the basis of routine treatment. The total effective rate, mortality and NIHSS score were compared between the two groups. ADL score and the incidence of adverse reactions. Results: (1) after treatment, the total effective rate of the study group was significantly higher than that of the routine group, and the mortality was significantly lower than that of the routine group (P0.05). (2). The NIHSS score of the study group was significantly lower than that of the routine group, and the ADL score of the study group was significantly higher than that of the routine group. The difference was statistically significant (P0.05). (3). There was no significant difference in the incidence of adverse reactions between the two groups (P0.05). Conclusion: in addition to routine treatment of patients with large area cerebral infarction, the effect of Urikline and butadieneptide is remarkable, which can effectively improve the effect of treatment and reduce the mortality of patients with cerebral infarction, and it is safe to use drugs.
【作者单位】： 福建医科大学附属泉州市第一医院神经内科;
【分类号】：R743.33
【相似文献】
相关期刊论文 前10条
1 姚建华;宋春伶;杨鑫;;尤瑞克林治疗基底动脉尖综合征30例临床观察[J];中国老年学杂志;2008年18期
2 林兴建;过燕萍;徐俊;孙丰;陈俊;张颖冬;;尤瑞克林治疗短暂性脑缺血发作的疗效观察[J];山东医药;2009年01期
3 方伯言;贾玉洁;杨波;杨锐;贾宁;闵连秋;;尤瑞克林治疗短暂性脑缺血发作26例疗效观察[J];山东医药;2009年37期
4 陈玉s，
本文编号：2370317
本文链接：https://www.wllwen.com/yixuelunwen/shenjingyixue/2370317.html
最近更新
教材专著
